Grace Therapeutics Announces Third Fiscal Quarter 2025Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical…
ACKO’s E-challan Platform Revolutionises Traffic Fine Management
NEW DELHI, Jan. 23, 2025 /PRNewswire/ -- ACKO is India's pioneering digital-first…
ACKO’s E-challan Platform Revolutionises Traffic Fine Management
NEW DELHI, Jan. 23, 2025 /PRNewswire/ -- ACKO is India's pioneering digital-first…
ACKO’s E-challan Platform Revolutionises Traffic Fine Management
NEW DELHI, Jan. 23, 2025 /PRNewswire/ -- ACKO is India's pioneering digital-first…
U.S. Food and Drug Administration Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given…
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz
** IND submitted to the FDA showing significantly improved patient condition when…
Investigational Epcoritamab (DuoBody CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Media ReleaseCOPENHAGEN, Denmark; December 7, 2024 Results show 96 percent overall response…
NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis
MILAN, Dec. 5, 2024 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical…